2023 Annual General Meeting Results
Released
Released
Announcement PDF
ASX Announcement
23 May 2023
2023 Annual General Meeting Results
Melbourne, Australia, 23 May 2023 – In accordance with ASX Listing Rule 3.13.2 and section 251AA of
the Corporations Act 2001 (Cth), Avecho Biotechnology Limited (ASX: AVE) advises that the details of the
resolutions and the proxies received in respect of each resolution at its Annual General Meeting today are
set out in the attached proxy summary.
For enquiries, please contact
Melanie Leydin
Company Secretary
+61 3 9692 7222
This announcement has been authorised by the Board of Directors of Avecho Biotechnology Limited.
About Avecho
Avecho Biotechnology Limited (ASX: AVE) develops and commercialises innovative Human and Animal Health
products using its proprietary drug delivery system called TPM®. TPM® is derived from Vitamin E using
unique, proprietary and patented processes and is proven to enhance the solubility and oral, dermal and
transdermal absorption of drugs and nutrients.
Avecho’s major projects include delivering TPM® enhanced injectable, oral and topical products for the
human health market and is also developing TPM® to enhance the feed efficiency and health of livestock.
New additions to the development program include the recently announced application of TPM® to
cannabinoids.
See more here - avecho.com.au
Avecho Biotechnology Limited | ASX:AVE | ACN: 056 482 403 | ABN: 32 056 482 403
Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168
avecho.com.au
Annual General Meeting
Tuesday 23 May 2023
Voting Results
The following information is provided in accordance with section 251AA(2) of Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.
Show of
Hands
(S) or
Poll (P)
Resolution Details
Resolution
Resolution
Type
If
s259U
applies
S or P
Instructions given to validly appointed proxies
(as at proxy close)
For
Against
Proxy’s
Discretion
Abstain
215,285,950
3,868,748
8,009,657
94.77%
1.70%
3.53%
238,623,222
546,225
96.61%
Number of votes cast on the poll
(where applicable)
Abstain
For
Against
2,692,416
544,377,394
3,868,748
2,692,416
-
99.29%
0.71%
-
7,829,657
291,841
583,117,998
546,225
291,841
0.22%
3.17%
-
99.91%
0.09%
-
236,627,222
642,225
9,729,657
291,841
567,717,720
15,946,503
291,841
95.80%
0.26%
3.94%
-
97.27%
2.73%
-
214,597,045
6,482,036
7,683,824
18,528,040
543,362,656
6,482,036
18,528,040
93.81%
2.83%
3.36%
-
98.82%
1.18%
-
147,523,705
5,287,036
8,078,026
86,402,178
426,508,027
71,045,859
86,402,178
91.69%
3.29%
5.02%
-
85.72%
14.28%
-
146,941,705
5,127,036
8,574,657
86,647,547
426,422,658
70,885,859
86,647,547
91.47%
3.19%
5.34%
-
85.75%
14.25%
-
Resolution
Result
Carried/
Not
Carried
1
Adoption of Remuneration
Report
Ordinary
N/A
P
2
Re-Election of Dr Gregory
Collier as a Director of the
Company
Ordinary
N/A
P
3
Re-Election of Mr Matthew
Patrick McNamara as a
Director of the Company
Ordinary
N/A
P
4
Renewal of Avecho
Biotechnology Limited
Equity Incentive Plan
Ordinary
N/A
P
5a
Approval for the issue of
JLM Options to CoPeak
Corporate Pty Ltd
Ordinary
N/A
P
5b
Approval for the issue of
JLM Options to CPS
Capital Group Pty Ltd
Ordinary
N/A
P
5c
Ratify the issue of JLM
Options to CoPeak
Corporate Pty Ltd
Ordinary
N/A
N/A
This motion was withdrawn as announced on 18 May 2023.
N/A
5d
Ratify the issue of JLM
Options to CPS Capital
Group Pty Ltd
Ordinary
N/A
N/A
This motion was withdrawn as announced on 18 May 2023.
N/A
6
Approval
of
Placement Facility
Special
N/A
P
10%
232,920,787
2,550,437
11,010,055
809,666
580,595,961
2,550,437
809,666
94.51%
1.03%
4.46%
-
99.56%
0.44%
-
Carried
Carried
Carried
Carried
Carried
Carried
Carried
*Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.
Avecho Biotechnology Limited | ASX:AVE | ACN: 056 482 403 | ABN: 32 056 482 403
Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168
avecho.com.au
Share your feedback
Discover